Beta Cell Differentiation
Beta Cell Differentiation - Related Videos
10:12
Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System
0 Views •
Cited by 4 •
2021
The present protocol describes an enhanced method to increase the co-expression of PDX1 and NKX6.1 transcription factors in pancreatic progenitors derived from human pluripotent stem cells (hPSCs) in planar monolayers. This is achieved by replenishing the fresh matrix, manipulating cell density, and dissociating the endodermal cells.
09:50
In situ Quantification of Pancreatic Beta-cell Mass in Mice
0 Views •
Cited by 6 •
2010
The following protocol outlines the process of pancreatic dissection for virtual slice imaging, and the subsequent quantification of all GFP-tagged beta-cells in the entire pancreas.
12:12
Methods to Assess Beta Cell Death Mediated by Cytotoxic T Lymphocytes
0 Views •
Cited by 14 •
2011
Cell-mediated lymphocytotoxicity (CML) assays can be used to test autoreactive responses and study mechanisms of cell death in vitro. However, using live-cell confocal microscopic imaging techniques with fluorescent dyes, the type and kinetics of cell death as well as the pathways utilized can be studied in greater detail.
01:25
Beta
0 Views •
2024
Beta is a crucial metric in finance used to assess an investment's risk and expected return relative to the overall market. It is calculated as the slope of the line in a scatterplot that compares the returns of an individual stock to the returns of the market benchmark, typically represented by a broad market index. Beta quantifies how much a stock's price moves in response to market movements, providing insight into its volatility and systematic risk. A beta of one indicates that the stock's...
04:16
Imaging Transgenic Beta-Cells in an Immunodeficient Mouse Challenged with Diabetic Splenocytes
0 Views •
2025
This video demonstrates an imaging-based method to visualize transplanted luciferase-expressing beta cells into a non-obese diabetic immunodeficient mouse. The introduction of splenocytes from a diabetic mouse leads to progressive beta cell destruction, visually confirmed by declining luminescence after substrate introduction.
FAQs
These factors represent coordinated stages in the developmental program rather than interchangeable markers. PDX1, NGN3, NEUROD1, and MAFA are activated as cells move through pancreatic progenitor development, endocrine commitment, beta cell specification, and functional maturation. Examining their ordered participation helps researchers connect molecular regulation with the acquisition of beta cell identity.
The process proceeds through linked developmental transitions. Pancreatic progenitor cells first enter an endocrine pathway, then acquire beta cell-specific identity, and finally develop mature function associated with insulin production. This progression matters because cellular identity and functional maturation are related but distinct outcomes, allowing developmental studies to determine where normal formation or failure occurs.
Coordinated signaling does more than establish individual cell identities. It helps guide how pancreatic cells develop within organized tissue, linking the emergence of beta cells with broader pancreatic development. In developmental biology, this relationship provides a framework for studying how molecular programs and tissue-level organization arise together rather than treating beta cells as isolated cell types.
Researchers can use pluripotent stem cell systems to study whether developmental programs can produce beta cells outside the original developmental setting. These models provide a way to investigate the sequence from pancreatic progenitor states through endocrine commitment, specification, and maturation. They are especially relevant for diabetes research because they support efforts to generate beta cells for experimental study.
Following the developmental programs that establish beta cell identity can clarify how beta cells form and how their failure may arise. Researchers can compare normal differentiation with mechanisms associated with beta cell failure, using the developmental sequence as a reference. This perspective connects early pancreatic development with questions about glucose regulation and disease-related loss of beta cell function.
Understanding the signals and transcriptional factors associated with beta cell formation can inform attempts to produce replacement cells. Pluripotent stem cell research applies this developmental knowledge to generate beta cells for diabetes studies, while regenerative approaches use it to consider how beta cell populations might be restored. The developmental framework therefore links basic biology with potential therapeutic strategies.